X-15522497-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_203281.3(BMX):āc.662A>Gā(p.Lys221Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000165 in 1,211,066 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_203281.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BMX | NM_203281.3 | c.662A>G | p.Lys221Arg | missense_variant | 7/19 | ENST00000348343.11 | NP_975010.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BMX | ENST00000348343.11 | c.662A>G | p.Lys221Arg | missense_variant | 7/19 | 1 | NM_203281.3 | ENSP00000308774.6 |
Frequencies
GnomAD3 genomes AF: 0.0000177 AC: 2AN: 112955Hom.: 0 Cov.: 24 AF XY: 0.0000285 AC XY: 1AN XY: 35101
GnomAD3 exomes AF: 0.0000273 AC: 5AN: 183167Hom.: 0 AF XY: 0.0000295 AC XY: 2AN XY: 67735
GnomAD4 exome AF: 0.0000164 AC: 18AN: 1098111Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 6AN XY: 363511
GnomAD4 genome AF: 0.0000177 AC: 2AN: 112955Hom.: 0 Cov.: 24 AF XY: 0.0000285 AC XY: 1AN XY: 35101
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2024 | The c.662A>G (p.K221R) alteration is located in exon 7 (coding exon 6) of the BMX gene. This alteration results from a A to G substitution at nucleotide position 662, causing the lysine (K) at amino acid position 221 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at